FPR-1 knocks out and FPR-1 antagonist attenuated this inflammation process of acute lung injury; FPR-1 may be a novel therapeutic target for acute respiratory distress syndrome through the regulation of inflammation (Dorward et al., 2017). The gene discussed is FPR1; the disease is acute respiratory distress syndrome.